John L. Lamattina, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 4,000 shares at $194.51 ($778K) on 2018-06-04, disclosed to the SEC on 2018-06-04.
Open-market sale of $778k LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LGND | SELL | 2025-11-12 | $1.7M | — | Filing → |
| LGND | SELL | 2024-12-02 | $595K | — | Filing → |
| LGND | SELL | 2021-11-17 | $1.6M | — | Filing → |